Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA
Kateřina Menclová
World Journal of Gastroenterology, 2019
View PDFchevron_right
Early evaluation of circulating tumor DNA as marker of therapeutic efficacy in metastatic colorectal cancer patients (PLACOL study)
Valerie Taly
Clinical cancer research : an official journal of the American Association for Cancer Research, 2017
View PDFchevron_right
Circulating tumor DNA is a prognostic marker of tumor recurrence in stage II and III colorectal cancer: multicentric, prospective cohort study (ALGECOLS)
Valerie Taly
European Journal of Cancer, 2021
View PDFchevron_right
Clinical implications of monitoring circulating tumor DNA in patients with colorectal cancer
Lone Vedel Schøler
Clinical cancer research : an official journal of the American Association for Cancer Research, 2017
View PDFchevron_right
Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy
Giovanni Cigliana
Journal of Experimental & Clinical Cancer Research, 2020
View PDFchevron_right
Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
F. Mortensen
Gut, 2015
View PDFchevron_right
Clearance of circulating tumor DNA in a high-risk stage-IV rectal carcinoma patient with synchronous liver metastases after conversion surgery is correlated with pathologic complete response
Qiuxiang Ou
Therapeutic Advances in Gastrointestinal Endoscopy, 2021
View PDFchevron_right
Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery
Melissa Teo
Scientific reports, 2017
View PDFchevron_right
Clinical Applications of Minimal Residual Disease Assessments by Tumor-Informed and Tumor-Uninformed Circulating Tumor DNA in Colorectal Cancer
Yosef Nasseri
Cancers, 2021
View PDFchevron_right
Preoperative detection of KRAS mutated circulating tumor DNA is an independent risk factor for recurrence in colorectal cancer
Yuji Kitahata
Scientific Reports
View PDFchevron_right
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer
Jeffrey Clark
Clinical Cancer Research, 2021
View PDFchevron_right
The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer
Gianluca Tomasello
Clinical Cancer Research
View PDFchevron_right
Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study
Christos Karapetis
Gut, 2018
View PDFchevron_right
Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastases
Jaco Kraan
British Journal of Cancer, 2015
View PDFchevron_right
Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study
Pamela Pinzani
British Journal of Cancer, 2021
View PDFchevron_right
The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-Analysis
shiva Basnet
Journal of Cancer, 2016
View PDFchevron_right
Circulating Tumor DNA in Colorectal Cancer—From Concept to Clinic
Azim Jalali
Oncology & Hematology Review (US)
View PDFchevron_right
The Level of Preoperative Plasma KRAS Mutations and CEA Predict Survival of Patients Undergoing Surgery for Colorectal Cancer Liver Metastases
Jindra Vrzalova Windrichova
Cancers
View PDFchevron_right
Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial
Axel Hinke
Clinical Chemistry, 2020
View PDFchevron_right
RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients
Yang Ge
Canadian journal of gastroenterology & hepatology, 2018
View PDFchevron_right
Circulating tumor cell-related transcripts in blood as prognostic biomarkers of early recurrence after liver resection for colorectal metastases
Agostino Maria De Rose
The International Journal of Biological Markers, 2019
View PDFchevron_right
Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection
Halfdan Sorbye
PLoS genetics, 2016
View PDFchevron_right
The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
Susanne Pedersen
Frontiers in oncology, 2018
View PDFchevron_right
Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial
Clara Montagut
Clinical Cancer Research, 2021
View PDFchevron_right
Proof-of-Concept Pilot Study on Comprehensive Spatiotemporal Intra-Patient Heterogeneity for Colorectal Cancer With Liver Metastasis
George Koumbaris
Frontiers in Oncology, 2022
View PDFchevron_right
Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer
Sandra Fernandez
International Journal of Molecular Sciences
View PDFchevron_right
ctDNA to Guide Adjuvant Therapy in Localized Colorectal Cancer (CRC)
Clara Montagut
Cancers, 2021
View PDFchevron_right
Genome-Wide Scan for Copy Number Alteration Association with Relapse-Free Survival in Colorectal Cancer with Liver Metastasis Patients
Tzu-chi Hsu
Journal of clinical medicine, 2018
View PDFchevron_right
Frequent post-operative monitoring of colorectal cancer using individualised ctDNA validated by multiregional molecular profiling
Lance Liotta
British Journal of Cancer
View PDFchevron_right
Mutation and Methylation Analysis of Circulating Tumor DNA Can Be Used for Follow-up of Metastatic Colorectal Cancer Patients
Sonia Garrigou
Clinical colorectal cancer, 2018
View PDFchevron_right
Emerging Role of Circulating Tumour DNA in Treatment Response Prognosis in Colon Cancer
eveline anto
2021
View PDFchevron_right
Prognostic Significance of Multiple Molecular Markers for Patients With Stage II Colorectal Cancer Undergoing Curative Resection
Jaw yuan Wang
Annals of Surgery, 2007
View PDFchevron_right
Frequent post-treatment monitoring of colorectal cancer using individualized ctDNA validated by multi-regional molecular profiling
Lance Liotta
2020
View PDFchevron_right